Rare diseases - HCP - Therapy area
Top banner. ILARIS® (canakinumab).

Article
2
Periodic fever syndromes
Article - 25 Feb 2025
2
Top banner. ILARIS® (canakinumab).

Article
2
Familial Mediterranean fever (FMF)
Article - 25 Feb 2025
2

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.


Source URL: https://www.pro.novartis.com/uk-en/therapy-area/immunology